SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000008
Filing Date
2017-02-16
Accepted
2017-02-16 16:03:25
Documents
17
Period of Report
2017-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kjanuary2017mor_02162.htm 8-K 35801
2 EXHIBIT 99.1 di316januarymor.htm EX-99.1 4430
3 di316januarymor001.jpg GRAPHIC 94839
4 di316januarymor002.jpg GRAPHIC 25818
5 di316januarymor003.jpg GRAPHIC 14378
6 di316januarymor004.jpg GRAPHIC 120043
7 di316januarymor005.jpg GRAPHIC 217437
8 di316januarymor006.jpg GRAPHIC 151470
9 di316januarymor007.jpg GRAPHIC 80677
10 di316januarymor008.jpg GRAPHIC 104395
11 di316januarymor009.jpg GRAPHIC 118103
12 di316januarymor010.jpg GRAPHIC 139986
13 di316januarymor011.jpg GRAPHIC 73701
14 di316januarymor012.jpg GRAPHIC 86876
15 di316januarymor013.jpg GRAPHIC 158252
16 di316januarymor014.jpg GRAPHIC 101356
17 di316januarymor015.jpg GRAPHIC 128222
  Complete submission text file 0001338095-17-000008.txt   2234618
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17617892
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences